Stay updated on Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.

Latest updates to the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding notice and the earlier Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check30 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision to v3.4.1, while removing the v3.4.0 reference. These maintenance updates do not modify the study data or core content.SummaryDifference0.4%

- Check37 days agoChange DetectedAdded an explicit 'Show glossary' option and updated QC-related metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check51 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded a Locations section listing sites in New York and Pennsylvania; updated page revision to v3.3.3.SummaryDifference0.3%

- Check101 days agoChange DetectedThe page revision updates the software version from v3.2.0 to v3.3.2 and does not affect study content or displayed information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.